Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver
Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver
复制标题
DOI：
10.1186/s12954-017-0152-3
复制
发表时间：
2017-05-18
影响因子：
4.4
通讯作者：
MacPherson, Donald
中科院分区：
文献类型：
--
作者：
Boyd, Susan;Murray, Dave;MacPherson, Donald
工作背景：本文重点介绍了一个同行运行组，SALOME/NAOMI患者协会（SNAP），每周在温哥华，不列颠哥伦比亚省，加拿大的市中心东区举行会议的经验。SNAP是一个独特的独立的同行运行的药物使用者组，成立于2011年后，加拿大的第一个海洛因辅助治疗试验（HAT），北美阿片类药物倡议（NAOMI）。SNAP的成员现在由前研究参与者组成，他们参加了温哥华的两项海洛因辅助试验。本文重点介绍了SNAP成员作为研究对象在加拿大温哥华进行的第二项临床试验中的经验，评估长期阿片类药物疗效的研究（SALOME），该研究于2011年开始招募研究参与者。本文借鉴了一次头脑风暴会议，三个焦点小组和实地考察，2013年底，与SALOME/NAOMI患者协会（SNAP）讨论了他们作为加拿大第二项临床试验（温哥华DTES的SALOME）研究对象的经历，以及与SNAP成员一起进行为期6年（2011年3月至2017年2月）的实地考察。SNAP的研究借鉴了药物使用者团体和关键的方法论框架开发的研究原则，以社区为基础的研究，为社会justice.Results：结果阐明如何参与SALOME临床试验影响SNAP成员的生活。此外，研究结果揭示了SNAP成员对HAT的倡导如何以积极的方式影响该组织。从分析的头脑风暴和焦点小组的七大主题出现：生活之前SALOME，诊所设置和常规，稳定性，6个月的过渡，支持，退出审判和道德，集体行动，包括他们在宪法的挑战参与BC省最高法院继续接受HAT一旦SALOME审判结束。他们认为，应该在加拿大建立永久性的HAT计划，因为它们是一个有效的减少伤害的倡议，也可以减少阿片类药物过量死亡。
Background: This article highlights the experiences of a peer-run group, SALOME/NAOMI Association of Patients (SNAP), that meets weekly in the Downtown Eastside of Vancouver, British Columbia, Canada. SNAP is a unique independent peer-run drug user group that formed in 2011 following Canada's first heroin-assisted treatment trial (HAT), North America Opiate Medication Initiative (NAOMI). SNAP's members are now made up of former research participants who participated in two heroin-assisted trials in Vancouver. This article highlights SNAP members' experiences as research subjects in Canada's second clinical trial conducted in Vancouver, Study to Assess Longer-term Opioid Medication Effectiveness (SALOME), that began recruitment of research participants in 2011.Methods: This paper draws on one brainstorming session, three focus groups, and field notes, with the SALOME/NAOMI Association of Patients (SNAP) in late 2013 about their experiences as research subjects in Canada's second clinical trial, SALOME in the DTES of Vancouver, and fieldwork from a 6-year period (March 2011 to February 2017) with SNAP members. SNAP's research draws on research principles developed by drug user groups and critical methodological frameworks on community-based research for social justice.Results: The results illuminate how participating in the SALOME clinical trial impacted the lives of SNAP members. In addition, the findings reveal how SNAP member's advocacy for HAT impacts the group in positive ways. Seven major themes emerged from the analysis of the brainstorming and focus groups: life prior to SALOME, the clinic setting and routine, stability, 6-month transition, support, exiting the trial and ethics, and collective action, including their participation in a constitutional challenge in the Supreme Court of BC to continue receiving HAT once the SALOME trial ended.Conclusions: HAT benefits SNAP members. They argue that permanent HAT programs should be established in Canada because they are an effective harm reduction initiative, one that also reduces opioid overdose deaths.